Swedish Orphan Biovitrum AB (publ)
STO:SOBI
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Swedish Orphan Biovitrum AB (publ)
Other Receivables
Swedish Orphan Biovitrum AB (publ)
Other Receivables Peer Comparison
Competitive Other Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Other Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Other Receivables
kr2.4B
|
CAGR 3-Years
38%
|
CAGR 5-Years
18%
|
CAGR 10-Years
34%
|
|
Biogaia AB
STO:BIOG B
|
Other Receivables
kr27.6m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
Hansa Biopharma AB
STO:HNSA
|
Other Receivables
kr42.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bonesupport Holding AB
STO:BONEX
|
Other Receivables
kr35.2m
|
CAGR 3-Years
72%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
Vitrolife AB
STO:VITR
|
Other Receivables
kr70m
|
CAGR 3-Years
87%
|
CAGR 5-Years
53%
|
CAGR 10-Years
18%
|
|
BioArctic AB
STO:BIOA B
|
Other Receivables
kr6.9m
|
CAGR 3-Years
7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Swedish Orphan Biovitrum AB (publ)'s Other Receivables?
Other Receivables
2.4B
SEK
Based on the financial report for Mar 31, 2024, Swedish Orphan Biovitrum AB (publ)'s Other Receivables amounts to 2.4B SEK.
What is Swedish Orphan Biovitrum AB (publ)'s Other Receivables growth rate?
Other Receivables CAGR 10Y
34%
Over the last year, the Other Receivables growth was 10%. The average annual Other Receivables growth rates for Swedish Orphan Biovitrum AB (publ) have been 38% over the past three years , 18% over the past five years , and 34% over the past ten years .